Concentric Capital Strategies, LP Boston Scientific Corp Transaction History
Concentric Capital Strategies, LP
- $1.94 Billion
- Q2 2024
A detailed history of Concentric Capital Strategies, LP transactions in Boston Scientific Corp stock. As of the latest transaction made, Concentric Capital Strategies, LP holds 42,370 shares of BSX stock, worth $3.59 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
42,370
Previous 32,312
31.13%
Holding current value
$3.59 Million
Previous $2.21 Million
47.4%
% of portfolio
0.17%
Previous 0.12%
Shares
4 transactions
Others Institutions Holding BSX
# of Institutions
1,467Shares Held
1.21BCall Options Held
8.13MPut Options Held
8.3M-
Vanguard Group Inc Valley Forge, PA130MShares$11 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY126MShares$10.7 Billion0.22% of portfolio
-
State Street Corp Boston, MA61.5MShares$5.21 Billion0.21% of portfolio
-
Primecap Management CO Pasadena, CA38MShares$3.22 Billion2.15% of portfolio
-
Wellington Management Group LLP Boston, MA32.1MShares$2.72 Billion0.45% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $121B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...